So back in late 2017 the Cochrane Collaboration made the bold claim that treatment with Direct Acting Antivirals did not have any measurable impact on clinical outcomes. While the medical profession as a whole expressed a large and collective WTF sentiment new research published in the Lancet – “Clinical outcomes in patients with chronic hepatitis […]
Tag Archives: hep c
07
Apr
Apr
They say (who are they anyway?) “If it seems to good to be true it probably is”. When it comes to generic Hepatitis C medication some people struggle with the idea that something like Harvoni® with a list price of $94,000 USD could be manufactured for under $1000 USD. Surely if the original costs $94,000 […]
01
Jan
Jan
A quick note on how to take your DAA medication. Read the package insert and follow the instructions with respect to with (or without) food. For example, for Vosevii Administration with food enhances the oral bioavailability of sofosbuvir, velpatasvir, and voxilaprevir. Relative to fasting conditions, mean sofosbuvir systemic exposure (AUC) increased by 64% to 144%, […]
11
Aug
Aug
By Priti Krishtel Last week, the FDA approved AbbVie’s Mavyret—a new hepatitis C virus (HCV) drug that treats all genotypes of the disease and cures more than 90% of patients within just 8 weeks of treatment. This has been reported as a threat to Gilead Sciences’ dominant position in the market, sparking rumors of a […]
17
Oct
Oct
Here is some interesting data from the Google Analytics about the FixHepC visitor demographics. It’s kind of spooky that Google knows your age and sex, but here’s their analysis. One of the interesting things is that with 1% of the population infected if you consider the impact of spouses and voting age children an organised […]